Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose.
VEGF
exosomes
miRNAs
resolvin D1
retinal photoreceptors
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
09
2019
accepted:
20
02
2020
entrez:
27
3
2020
pubmed:
27
3
2020
medline:
27
3
2020
Statut:
epublish
Résumé
Stimulation of retinal photoreceptors with elevated glucose concentration (30 mM) for 96 h, served as diabetic retinopathy
Identifiants
pubmed: 32210819
doi: 10.3389/fphar.2020.00235
pmc: PMC7069219
doi:
Types de publication
Journal Article
Langues
eng
Pagination
235Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 Maisto, Trotta, Petrillo, Izzo, Cuomo, Alfano, Hermenean, Barcia, Galdiero, Platania, Bucolo and D’Amico.
Références
Cochrane Database Syst Rev. 2014 Feb 14;(2):CD009122
pubmed: 24526393
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3613-20
pubmed: 19443724
Sci Rep. 2018 Sep 27;8(1):14493
pubmed: 30262875
IUBMB Life. 2015 Mar;67(3):145-59
pubmed: 25899846
Oncotarget. 2017 Aug 24;8(44):77369-77384
pubmed: 29100393
Oncotarget. 2017 Dec 14;9(25):17257-17269
pubmed: 29707106
Biomed Hub. 2017 Feb 21;2(1):1-12
pubmed: 31988905
Br J Pharmacol. 2019 Jul;176(13):2179-2194
pubmed: 30883703
PLoS One. 2009;4(3):e4722
pubmed: 19266099
FASEB J. 2011 Feb;25(2):544-60
pubmed: 20956612
Exp Eye Res. 2019 Mar;180:53-62
pubmed: 30513286
Stem Cell Reports. 2018 Sep 11;11(3):665-680
pubmed: 30100409
Mediators Inflamm. 2015;2015:126408
pubmed: 26180376
Retina. 2013 Mar;33(3):542-7
pubmed: 23400083
Mucosal Immunol. 2019 Jan;12(1):145-153
pubmed: 30279513
Pharmacol Rep. 2009 Jul-Aug;61(4):595-603
pubmed: 19815941
Curr Diabetes Rev. 2009 Feb;5(1):8-13
pubmed: 19199892
PLoS One. 2017 Nov 2;12(11):e0185383
pubmed: 29095817
Aging (Albany NY). 2019 Aug 14;11(15):5817-5828
pubmed: 31412320
Mol Neurobiol. 2018 Aug;55(8):6894-6905
pubmed: 29357041
Nutrition. 2013 Jan;29(1):1-7
pubmed: 22677359
J Diabetes Investig. 2010 Jun 1;1(3):77-89
pubmed: 24843412
FEBS Lett. 2018 Sep;592(17):2973-2986
pubmed: 30025156
Acta Biochim Biophys Sin (Shanghai). 2016 Aug;48(8):732-40
pubmed: 27421659
Mol Cancer. 2015 Jul 16;14:133
pubmed: 26178901
Mol Vis. 2017 Apr 14;23:242-250
pubmed: 28465656
Endocrinol Metab Clin North Am. 2004 Mar;33(1):215-38, xi-xii
pubmed: 15053904
Mediators Inflamm. 2012;2012:318621
pubmed: 23304060
Cell Cycle. 2019 Feb;18(4):413-424
pubmed: 30739530
Biochim Biophys Acta. 2015 Apr;1851(4):469-84
pubmed: 25149823
Front Pharmacol. 2017 Nov 07;8:798
pubmed: 29163178
J Cell Mol Med. 2017 May;21(5):968-974
pubmed: 27998021
Int J Mol Sci. 2018 Mar 22;19(4):
pubmed: 29565290
Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):3770-5
pubmed: 25775553
Nat Rev Immunol. 2008 May;8(5):349-61
pubmed: 18437155
J Cell Physiol. 2020 May;235(5):4256-4267
pubmed: 31612492
J Diabetes Complications. 2016 May-Jun;30(4):738-45
pubmed: 26781070
Oxid Med Cell Longev. 2017;2017:2825703
pubmed: 29163753
Front Pharmacol. 2018 Dec 19;9:1488
pubmed: 30618774
Nat Med. 2007 Jul;13(7):868-873
pubmed: 17589522
Prostaglandins Other Lipid Mediat. 2016 Mar;123:28-32
pubmed: 27026343
Mol Vis. 2018 Apr 01;24:274-285
pubmed: 29643724
Front Immunol. 2012 Oct 22;3:298
pubmed: 23093949
Mediators Inflamm. 2015;2015:149381
pubmed: 25684860
Exp Diabetes Res. 2007;2007:43603
pubmed: 17641741
Br J Pharmacol. 2017 Jul;174(14):2393-2408
pubmed: 28471519